Skip to content
healthcare.dev

Doxazosin

NDC 0832-0357, Doxazosin Mesylate, tablet, from Upsher-Smith laboratories, LLC.

Product NDC
0832-0357
Status
Listed
Labeler
Upsher-Smith laboratories, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0832-0357 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
0832-0357-1100832035711100 TABLET in 1 BOTTLE (0832-0357-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b5d1c604-ce3b-4973-845f-9db267a945cd
  • NADAC price for package 00832035711

    GET /v1/drugs/nadac/00832035711

Use it

Look up 0832-0357 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0832-0357 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0832-0357. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.